Enanta Pharmaceuticals
ENTA
ENTA
117 hedge funds and large institutions have $380M invested in Enanta Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 29 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less call options, than puts
Call options by funds: $430K | Put options by funds: $1.24M
Holders
117
Holding in Top 10
2
Calls
$430K
Puts
$1.24M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$14.8M | |
| 3 | +$13.6M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
+$13M |
| 5 |
Millennium Management
New York
|
+$7.87M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$12.2M | |
| 3 | -$6.48M | |
| 4 |
Lazard Asset Management
New York
|
-$4.76M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$4.38M |